Citation Impact
Citing Papers
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets
1996
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
Beam-foil production of fast positronium
1985
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy‐induced nausea and vomiting
2003
Molecular imaging in drug development
2008 Standout
Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists
2003
Correlation of Neurokinin (NK) 1 Receptor Occupancy in Gerbil Striatum with Behavioral Effects of NK1 Antagonists
2002
Bowel Disorders
2016 Standout
Optimising antiemetic therapy: what are the problems and how can they be overcome?
2005
The novel NK1 receptor antagonist MK–0869 (L–754,030) and its water soluble phosphoryl prodrug, L–758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets
2000
Descending control of pain
2002 Standout
Theoretical Chemistry of Gold
2004 Standout
Substance P receptor antagonists in the therapy of migraine
2001
Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor Antagonist
1999
Potential of Substance P Antagonists as Antiemetics
2000
THE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGS
2004
New perspectives in antiemetic treatment
1996
A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy
2006
Transition metal-catalyzed C–H activation reactions: diastereoselectivity and enantioselectivity
2009 Standout
Adenosine receptors as therapeutic targets
2006 Standout
Prospective evaluation of antiemetic outcome following high-dose chemotherapy with hematopoietic stem cell support
2001
Modulation of gastrointestinal function by MuDelta, a mixed µ opioid receptor agonist/ µ opioid receptor antagonist
2012
Network pharmacology: the next paradigm in drug discovery
2008 Standout
The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles
1998
Roles of Substance P and NK1 Receptor in the Brainstem in the Development of Emesis
2003
Selectivity of action of 8‐alkylamino analogues of N6‐cyclopentyladenosine in vivo: haemodynamic versus anti‐lipolytic responses in rats
1998
Effect of the Adenosine A1 Receptor Agonist Gr79236 on Trigeminal Nociception with Blink Reflex Recordings in Healthy Human Subjects
2003
Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: A comparison to other agents
2008
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Aromatic C–F activation by complexes containing the {Pt2S2} core via nucleophilic substitution: a combined experimental and theoretical study
2009
Drug Treatment of Chemotherapy-Induced Delayed Emesis
1996
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Rolapitant (SCH 619734): A potent, selective and orally active neurokinin NK1 receptor antagonist with centrally-mediated antiemetic effects in ferrets
2012
Direct Oxidative Heck Cyclizations: Intramolecular Fujiwara–Moritani Arylations for the Synthesis of Functionalized Benzofurans and Dihydrobenzofurans
2004
Alvimopan, a selective peripherally acting μ‐opioid antagonist*
2005
Physiology of Chemotherapy-Induced Emesis and Antiemetic Therapy
1997
Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy‐induced nausea and vomiting
2003
Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis
2001
In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists
1997
Mu-Opioid Receptors and Dietary Protein Stimulate a Gut-Brain Neural Circuitry Limiting Food Intake
2012
Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the rat
2007
2,5-Diketopiperazines as potent and selective oxytocin antagonists 1: identification, stereochemistry and initial SAR
2005
Deficits in visceral pain and hyperalgesia of mice with a disruption of the tachykinin NK1 receptor gene
2000
Reversal of behavioural and electrophysiological correlates of experimental peripheral neuropathy by the NK1 receptor antagonist GR205171 in rats
1998
Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
2014 Standout
Angiotensin II Receptor Antagonists: An Emerging New Class of Cardiovascular Therapeutics.
1999
Neuropathic Pain Activates the Endogenous κ Opioid System in Mouse Spinal Cord and Induces Opioid Receptor Tolerance
2004 StandoutNobel
High-Precision Optical Measurement of the2 S
2004 StandoutNobel
The development and evaluation of the Earth Gravitational Model 2008 (EGM2008)
2012 Standout
Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer After Moderately Emetogenic Chemotherapy
2005
Heterobimetallic Dinitrogen Complexes That Contain the {[N3N]Mo−NN}-Ligand
1998 StandoutNobel
3d Transition Metals for C–H Activation
2018 Standout
Fluorine in medicinal chemistry
2007 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
The fine structure constant
1996
Hyperfine structure of the ground and first excited states in light hydrogen-like atoms and high-precision tests of QED
2002
Anomalous magnetic moment of the muon and the ground-state hyperfine splitting of muonium
1995
The g factor in a light two-body atomic system: a determination of fundamental constants to test QED
2002
Determination of the fine-structure constant by a precise measurement ofh/mn: the final result
1998
General pharmacology of SDZ WAG 994, a potent selective and orally active adenosine A1 receptor agonist
1995
High Precision Measurements of the Ground State Hyperfine Structure Interval of Muonium and of the Muon Magnetic Moment
1999
Pharmacokinetic Evaluation of N-[2-(Dimethylamino)Ethyl]Acridine-4-Carboxamide in Patients by Positron Emission Tomography
2001
CODATA recommended values of the fundamental physical constants: 2002
2005
Weak-interaction contributions to hyperfine splitting and Lamb shift
1996
All-Order Binding Corrections to Muonium Hyperfine Splitting
1997
The Many Roles for Fluorine in Medicinal Chemistry
2008 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Theory of positrons in solids and on solid surfaces
1994 Standout
To Bend or Not To Bend: Dilemma of the Edge-Sharing Binuclear Square Planar Complexes of d8 Transition Metal Ions
1998
Synthesis of Titanium and Zirconium Complexes That Contain the Tridentate Diamido Ligand, [((t-Bu-d6)N-o-C6H4)2O]2- ([NON]2-) and the Living Polymerization of 1-Hexene by Activated [NON]ZrMe2
1997 StandoutNobel
CODATA recommended values of the fundamental physical constants: 1998
2000
Virtual light-by-light scattering and theg
2005
Logarithmic terms in muonium hyperfine splitting
1989
Observation of resonance line narrowing for old muonium
1995
Catalytic Dehydrogenative Cross-Coupling: Forming Carbon−Carbon Bonds by Oxidizing Two Carbon−Hydrogen Bonds
2011 Standout
Recoil effects in the hyperfine structure of QED bound states
1985
Leading logarithmic corrections and uncertainty of Muonium hyperfine splitting calculations
1996
Second order in mass ratio radiative-recoil corrections to hyperfine splitting in muonium
1998
Transition-Metal-Catalyzed C−S, C−Se, and C−Te Bond Formation via Cross-Coupling and Atom-Economic Addition Reactions
2011 Standout
Randomized Phase II Study of the Neurokinin 1 Receptor Antagonist CJ-11,974 in the Control of Cisplatin-Induced Emesis
1999
An Introduction to Econophysics: Correlations and Complexity in Finance
2000 Standout
“Fixation” of Dinitrogen by Molybdenum and the Formation of a Trigonal Planar Iron−Tris[molybdenum(dinitrogen)] Complex
1997 StandoutNobel
Benzofuran synthesis via copper-mediated oxidative annulation of phenols and unactivated internal alkynes
2013
Improved theory of the muonium hyperfine structure
1994
Precision measurement of ?/m Cs based on photon recoil using laser-cooled atoms and atomic interferometry
1994 StandoutNobel
Radiative corrections to the muonium hyperfine structure: Theα 2
1996
Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting
2007
Implanted muon studies in condensed matter science
1987
Radiative-recoil corrections to muonium and positronium hyperfine splitting
1984
Ruthenium(II)-Catalyzed C–H Bond Activation and Functionalization
2012 Standout
Theory of the hydrogen-deuterium isotope shift
1994 StandoutNobel
Corrections of orderα 2 ) 5
1995
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
Generation of Thermal Muonium in Vacuum
1986
Precision measurement of the magnetic field in terms of the free-proton NMR frequency
1997
Absolute Optical Frequency Measurement of the CesiumD 1
1999 StandoutNobel
Emission of Muonium into Vacuum from a Silica-Powder Layer
1986
Theory of light hydrogenlike atoms
2001
Purely radiative contribution to muonium and hydrogen hyperfine splitting induced by light by light scattering insertion in external photons
1991
Cannabinoids for Medical Use
2015 Standout
Structural, Dynamic, and Theoretical Studies of [AunPt2(PPh3)4(μ-S)2-n(μ3-S)nL][PF6]n [n = 1, L = PPh3; n = 2, L = Ph2PCH2PPh2, (C5H4PPh2)2Fe]
2000
New precision measurements of the muonic X-ray transition in 24Mg and 28Si: Vacuum polarisation test and search for muon-hadron interactions beyond QED
1986
Optics and interferometry with atoms and molecules
2009 Standout
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
2001 Standout
The Quantum Hall Effect and Resistance Standards
1992
Interaction of positron beams with surfaces, thin films, and interfaces
1988 Standout
Muonium states in semiconductors
1988
Measurement of the Lamb Shift in Muonium
1984
A Capacitance Standard Based on Counting Electrons
1999 StandoutScienceNobel
Last vacuum polarization contribution of order α2(Zα)EF to muonium and hydrogen hyperfine splitting
1990
α(Zα) 2 E F
1996
Integral quantum Hall effect for nonspecialists
1987
Laser Excitation of the Muonium1 S − 2 S
1988 StandoutNobel
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Applications of Fluorine in Medicinal Chemistry
2015 Standout
CODATA recommended values of the fundamental physical constants: 2010
2012 Standout
Prevention of Cisplatin-Induced Emesis by the Oral Neurokinin-1 Antagonist, MK-869, in Combination With Granisetron and Dexamethasone or With Dexamethasone Alone
2001
Hydrogen interactions with defects in crystalline solids
1992 Standout
A new term in muonium hyperfine splitting
1984
Transition Metal Complexes That Contain a Triamidoamine Ligand
1997 StandoutNobel
Precision measurement of the 1Sground-state Lamb shift in atomic hydrogen and deuterium by frequency comparison
1995 StandoutNobel
CODATA recommended values of the fundamental physical constants: 2006
2008
Structural Optimization Affording 2-(R)-(1-(R)-3,5-Bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a Potent, Orally Active, Long-Acting Morpholine Acetal Human NK-1 Receptor Antagonist
1998
The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
2003 Standout
The 1986 adjustment of the fundamental physical constants
1987 Standout
Positron Emission Tomography in CNS Drug Discovery and Drug Monitoring
2014
Muonium hyperfine structure and hadronic effects
2002
The Role of the Fundamental Constants of Physics in Metrology
1992
Low-Coordinate Iron Complexes Stabilized byN-(tert-Hydrocarbyl)anilide Ligation: Adduct Formation, Chemical Oxidation, and Nitric Oxide Complexation
1996
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 Standout
Works of C. Gardner being referenced
ANTIEMETIC ACTIVITY OF NEUROKININ NK1 RECEPTOR ANTAGONISTS IS MEDIATED CENTRALLY IN THE FERRET
1994
Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II
1999
Observation of Muonium in Vacuum
1981
GR205171: A novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity
1996
Cardiovascular effects of GR117289, a novel angiotensin AT1 receptor antagonist
1994
Inhibition of anaesthetic-induced emesis by a NK1 or 5-HT3 receptor antagonist in the house musk shrew, Suncus murinus
1998
The NK1antagonist GR203040 inhibits cyclophosphamide-induced damage in the rat and ferret bladder
1997
The effects of GR79236 on plasma fatty acid concentrations, heart rate and blood pressure in the conscious rat
1994
Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferrets
1993
The broad‐spectrum anti‐emetic activity of the novel non‐peptide tachykinin NK1 receptor antagonist GR203040
1995
Preclinical studies of opioids and opioid antagonists on gastrointestinal function
2004
Identification of potent and selective oxytocin antagonists. Part 2: further investigation of benzofuran derivatives
2002
Towards Understanding the Aetiology and Pathophysiology of the Emetic Reflex: Novel Approaches to Antiemetic Drugs
1996
Potent inhibition of both the acute and delayed emetic responses to cisplatin in piglets treated with GR205171, a novel highly selective tachykinin NK1 receptor antagonist
1998
Higher Precision Measurement of the hfs Interval of Muonium and of the Muon Magnetic Moment
1982
Precise Measurement of the Hyperfine-Structure Interval and Zeeman Effect in the Muonic Helium Atom
1982
Simple halogenonitrosyl anions of iron
1976
Chemistry of platinum sulphido-complexes. Part 4. Dimeric µ-alkyl-sulphido-complexes: crystal and molecular structures of [Pt2(µ-S)-(µ-SMe)(PPh3)4]PF6·MeOH and cis-[Pt2(µ-SMe)2(NO2)2(PPh3)2]
1984